Tissue Transglutaminase: A Candidate Effector Element of Physiological Cell Death
The metazoans possess a genetic program of cell death (defined morphologically as apoptosis) which plays a vital role in their development and maintainance of tissue homeostasis (Wyllie et al. 1980; Fesus et al. 1991b). Over the last few years, it has become clear that cells not only control their proliferative and differentiative pathways, but also need specific positive stimuli to survive (Fesus et al. 1991 b; Raff et al. 1992). In the absence of the appropriate survival signals, cells enter an active program of cell death which requires the participation of functionally distinct sets of genes (Arends and Wyllie 1991; Fesus et al. 1991b). Despite its widespread importance, little is yet known about the biochemical events leading to the physiological deletion of cells in tissues (Arends and Wyllie 1991; Fesus et al. 1991b). While the mechanisms of initiation and regulation of apoptosis have attracted the attention of many researchers, by far less interest has been focused on the effector genes that determine the irreversible phenotypical changes and clearance of the dying cells. These final events allows naturally occurring cell death to behave as a “social” phenomenon which does not produce damage or inflammation in tissues (Arends and Wyllie 1991; Fesus et al. 1991b). Several independent laboratories have shown tissue transglutaminase (tTG) to be a potentially important player in the last stage of the cell death program (for review see Piacentini et al. 1994).
KeywordsProgramme Cell Death Tissue Transglutaminase Effector Element Cell Death Gene Occur Cell Death
Unable to display preview. Download preview PDF.
- Ameisen JC, Capron A (1991) Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol Today 4: 102–105Google Scholar
- Diamond D, Sleckman B, Gregory T, Lasky L, Greestain J, Burakoff S (1990) Inhibition of CD4+T-Cell function by the HIV-envelope protein gp120. J Immunol 141: 3715–3717Google Scholar
- Gentile V, Saydak M, Chiocca EA, Akande O, Birckbicheler PJ, Lee KN, Stein JP, Davies PJA (1991) Isolation and characterization of cDNA clones to mouse macrophage and human endothelial cell tissue transglutaminases. J Biol Chem 264: 478–483Google Scholar
- Gougeon ML, Montagnier L (1992) New concepts in the mechanisms of CD4+ lymphocyte depletion in aids, and the influence of opportunistic infections. Res Microbiol 361–373Google Scholar
- Geenberg CS, Birckbichler P, Rice RH (1992) Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J 5: 3071–3077Google Scholar
- Piacentini M, Davies PJA, Fesus L (1994) Transglutaminase in cells undergoing apoptosis. In: Tornei LO, Cope FO (eds) Apoptosis II: the molecular basis of apoptosis in desease. Cold Spring Harbor Laboratory press, Cold Spring Harbor, pp 143–163Google Scholar
- Tarcsa E, Kedei N, Thomazy V, Fesus L (1993) An involucrin-like protein in hepatocytes serves as a substrate of tissue transglutaminase during apoptosis. J Biol Chem 267: 25648–25652Google Scholar